Press Release Summary:
The GLUCOCARD® Shine Express Family Glucose Monitoring Systems are designed for people with diabetes. The devices are audio-enabled and provide testing prompts and glucose test readings in either English or Spanish. They offer pre-meal, post-meal, and fasting test averaging and feature a hypoglycemia indicator that warns user when blood glucose levels are critically low. They allow users to wirelessly transmit data to a smartphone or another Bluetooth enabled device via ARK Care® Vita data management app.
Original Press Release:
ARKRAY USA Launches Two New Blood Glucose Monitoring Systems in the United States
MINNEAPOLIS, Nov. 26, 2018 /PRNewswire/ -- ARKRAY USA, Inc., a leader in diabetes care products, announced today the US launch of the GLUCOCARD® Shine Connex Bluetooth® enabled and the GLUCOCARD® Shine Express audio-enabled blood glucose monitoring systems (BGMS). ARKRAY's GLUCOCARD Shine family of BGMS now consists of four distinct meters that use the same test strip platform.
"We are excited to make these new blood glucose monitoring systems available to people with diabetes," said ARKRAY USAPresident Jonathan Chapman. "The ability to offer four blood glucose monitoring systems that use the same test strip platform demonstrates ARKRAY's commitment to provide people living with diabetes a wide assortment of tools to accurately test their blood glucose levels, effectively manage their diabetes and keep overall supply costs low."
The GLUCOCARD Shine Connex is a Bluetooth enabled meter that provides users the ability to wirelessly transmit data to a smartphone or another Bluetooth enabled device using ARKRAY's ARK Care® Vita data management app--compatible with both iOS and Android devices.
The GLUCOCARD Shine Express is an audio-enabled device that provides testing prompts and glucose test readings in either English or Spanish. Voice prompts help the user easily setup the system and start testing. The GLUCOCARD Shine Express is ideally suited for people who are visually impaired or prefer additional assistance.
Both systems meet stringent FDA accuracy criteria for Self-Monitoring Blood Glucose Test Systems for over-the-counter use. Only a small 0.5 µL blood sample size is required and test results take just 5 seconds. Additionally, both systems provide pre-meal, post-meal, and fasting test averaging and have a hypoglycemia indicator, which warns users when blood glucose levels are critically low.
About ARKRAY USA, Inc.
ARKRAY USA, Inc. is a division of ARKRAY, a global leader in diabetes care with headquarters in Kyoto, Japan. For more than half a century, ARKRAY has pioneered products to ensure that people who have diabetes - and the health professionals who care for them - can better manage the condition. ARKRAY currently does business in more than 80 countries worldwide and is the market leader in diabetes management in the long-term care market in the U.S. For more information, visit www.arkrayusa.com.
CONTACT: Patrick Murphy, ARKRAY USA, Inc., 952.746.2605, email@example.com
Web Site: http://www.arkrayusa.com